Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Informe acción SHSE:688336

Capitalización de mercado: CN¥14.3b

Sunshine Guojian Pharmaceutical (Shanghai) Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva4.3yrs

Actualizaciones recientes de la dirección

Recent updates

Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Has A Rock Solid Balance Sheet

Nov 19
Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Has A Rock Solid Balance Sheet

Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Oct 29
Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

There's Reason For Concern Over Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) Massive 30% Price Jump

Oct 01
There's Reason For Concern Over Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) Massive 30% Price Jump

What Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) P/E Is Not Telling You

Jul 25
What Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) P/E Is Not Telling You

Is Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) A Risky Investment?

Jun 20
Is Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) A Risky Investment?

If EPS Growth Is Important To You, Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Presents An Opportunity

May 24
If EPS Growth Is Important To You, Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Presents An Opportunity

We Think That There Are Issues Underlying Sunshine Guojian Pharmaceutical (Shanghai)'s (SHSE:688336) Earnings

Mar 31
We Think That There Are Issues Underlying Sunshine Guojian Pharmaceutical (Shanghai)'s (SHSE:688336) Earnings

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHSE:688336) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 04
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHSE:688336) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

CEO

Sunshine Guojian Pharmaceutical (Shanghai) no tiene CEO, o no tenemos datos al respecto.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Dongmei Su
Director2.2yrssin datossin datos
Jing Lou
Chairman of the Board8.7yrsCN¥993.10k4.08%
CN¥ 582.2m
Wei Zhang
Independent Director5.3yrsCN¥136.80ksin datos
Yongli Jin
Independent Director5.3yrsCN¥136.80ksin datos
Fanzhi Huang
Independent Director3.4yrsCN¥136.80ksin datos
Jing Wu
Employee Representative Supervisor3.2yrssin datossin datos

4.3yrs

Permanencia media

59yo

Promedio de edad

Junta con experiencia: La junta directiva de 688336 se considera experimentada (4.3 años de antigüedad promedio).